T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
CVB Financial
CVBF
$4.05B
| $1.6M | ﹤0.01% |
68,967
+16,873
| +32% | +$390K |
|
1777
Outfront Media
OUT
$5.29B
| $1.59M | ﹤0.01% |
56,990
+5,970
| +12% | +$154K |
|
1778
Viasat
VSAT
$11.4B
| $1.59M | ﹤0.01% |
32,683
-336
| -1% | -$15.5K |
|
1779
Herbalife
HLF
$1.28B
| $1.59M | ﹤0.01% |
52,518
+4,760
| +10% | +$186K |
|
1780
Erie Indemnity
ERIE
$13.5B
| $1.59M | ﹤0.01% |
9,028
+2,120
| +31% | +$381K |
|
1781
HF Sinclair
DINO
$16.3B
| $1.59M | ﹤0.01% |
39,886
+7,407
| +23% | +$260K |
|
1782
MillerKnoll
MLKN
$1.64B
| $1.59M | ﹤0.01% |
45,878
+1,708
| +4% | +$63K |
|
1783
Open Text
OTEX
$6.02B
| $1.58M | ﹤0.01% |
37,339
+18,803
| +101% | +$835K |
|
1784
Renasant Corp
RNST
$4B
| $1.58M | ﹤0.01% |
47,292
-857
| -2% | -$31.4K |
|
|
FL
1785
DELISTED
Foot Locker
FL
| $1.58M | ﹤0.01% |
53,257
+355
| +0.7% | +$13.6K |
|
1786
Otter Tail
OTTR
$3.87B
| $1.57M | ﹤0.01% |
25,167
-2,689
| -10% | -$169K |
|
1787
Universal Corp
UVV
$1.13B
| $1.57M | ﹤0.01% |
27,095
-1,590
| -6% | -$87.5K |
|
1788
Assured Guaranty
AGO
$3.29B
| $1.57M | ﹤0.01% |
24,696
-561
| -2% | -$32.2K |
|
1789
MSC Industrial Direct
MSM
$6.67B
| $1.56M | ﹤0.01% |
18,339
+720
| +4% | +$58.3K |
|
1790
Newmark Group
NMRK
$2.68B
| $1.56M | ﹤0.01% |
98,092
+3,878
| +4% | +$63.2K |
|
1791
DNOW Inc
DNOW
$3.04B
| $1.56M | ﹤0.01% |
141,270
-3,781
| -3% | -$36.6K |
|
1792
Medifast
MED
$130M
| $1.55M | ﹤0.01% |
9,086
+349
| +4% | +$65.8K |
|
1793
Applied Industrial Technologies
AIT
$13B
| $1.55M | ﹤0.01% |
15,102
+535
| +4% | +$53.3K |
|
1794
Navient
NAVI
$867M
| $1.55M | ﹤0.01% |
90,716
+4,088
| +5% | +$75K |
|
1795
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $1.54M | ﹤0.01% |
6,013
| – | – |
|
|
ONEM
1796
DELISTED
1Life Healthcare
ONEM
| $1.54M | ﹤0.01% |
138,818
-232,093
| -63% | -$2.6M |
|
|
FYBR
1797
DELISTED
Frontier Communications
FYBR
| $1.53M | ﹤0.01% |
55,443
+12,000
| +28% | +$331K |
|
1798
Graham Holdings Company
GHC
$5.03B
| $1.51M | ﹤0.01% |
2,467
-24
| -1% | -$14.4K |
|
|
LUMO
1799
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.51M | ﹤0.01% |
159,595
| – | – |
|
1800
Q2 Holdings
QTWO
$4.13B
| $1.5M | ﹤0.01% |
24,413
+4,108
| +20% | +$263K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.